News
Verona Pharma Announces Departure of Chief Medical Officer
LONDON, April 11, 2018-- Verona Pharma plc, a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, today announces that Kenneth Newman, M.D., has resigned from his position as Chief Medical Officer, effective April 30, 2018, to pursue other opportunities. The Company has...
LONDON, April 11, 2018-- Verona Pharma plc, a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, today announces that Kenneth Newman, M.D., has resigned from his position as Chief Medical Officer, effective April 30, 2018, to pursue other opportunities. The Company has...